Hot Stocks: Biogen Idec (NASDAQ:BIIB), Sanofi SA (NYSE:SNY), Roche Holding (OTCMKTS: RHHBY), Abbott Laboratories (NYSE:ABT)

Posted by on Feb 18, 2014

Biogen Idec Inc. (NASDAQ: BIIB) has announced that Chairman William D. Young will retire from the its board of directors as of the company’s 2014 annual meeting of stockholders. Young has been a member of the board since 1997 and has been chairman since 2010. He will be replaced by Stelios Papadopoulos, who has been a member of Biogen Idec’s board since 2008. Biogen Idec Inc (NASDAQ:BIIB)   stock opened at $329.48 in last session, and closed at $328.29, while the day range of BIIB stock is $327.10-331.74. The stock showed a  positive weekly performance of 4.04 %.

Sanofi SA (ADR) (NYSE:SNY) stock was downgraded from Buy to Neutral at Citigroup Inc. on January 23, 2014. Sanofi SA (ADR) (NYSE:SNY) shares in last session saw a decline of -1.44%, and closed at $50.79. Sanofi SA (ADR) (NYSE:SNY)  stock opened at $49.85, in last session and closed at $50.42, by gained 1.88%.The 52 week range of $46.16-55.94.Company’s market capitalization is $134.33 billion.

Roche Holding Ltd has purchased an exclusive license for Inovio Pharmaceuticals, Inc. (NYSE: INO)’s vaccines that target prostate cancer -the third and most common deadly type of cancer- and hepatitis B -an extremely infectious liver disease. Also, the Swiss company has acquired an option to license additional vaccine opportunities, in connection to the collaboration to further develop a research program in oncology. Roche Holding Ltd. (ADR) (OTCMKTS: RHHBY)   stock   gained 1.78% and finished the last session at $73.90. The EPS of the stock remained 3.62.Company’s market capitalization is $254.97 billion.

Abbott Laboratories (NYSE:ABT) to $46.00 in a research note issued on Wednesday, AnalystRatings.Net reports. The firm currently has a “buy” rating on the stock. Jefferies Group’s price target points to a potential upside of 18.80% from the company’s current price Abbott Laboratories (NYSE:ABT)   stock opened the session at $38.68, and closed the session at $38.81. The 52 week range of the ABT stock remained $32.70-39.86 and the day range was $38.55 – $38.98.

Leave a Reply

Your email address will not be published. Required fields are marked *